中孚药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
105
NMPA:105
Drug Approvals
Piperacillin Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用哌拉西林钠他唑巴坦钠
- Approval Number
- 国药准字H20093709
- Approval Date
- Dec 7, 2023
NMPA
Piperacillin Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用哌拉西林钠他唑巴坦钠
- Approval Number
- 国药准字H20093708
- Approval Date
- Nov 27, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H20237140
- Approval Date
- Oct 30, 2023
NMPA
Cytidine Disodium Triphosphate Injection
- Product Name
- 三磷酸胞苷二钠注射液
- Approval Number
- 国药准字H20067280
- Approval Date
- Aug 30, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H37023075
- Approval Date
- Aug 30, 2023
NMPA
Procaine Hydrochloride Injection
- Product Name
- 盐酸普鲁卡因注射液
- Approval Number
- 国药准字H37022509
- Approval Date
- Aug 30, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H37023072
- Approval Date
- Aug 30, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H37023074
- Approval Date
- Aug 30, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H37023073
- Approval Date
- Aug 30, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found